Key points are not available for this paper at this time.
Level 5 evidence on emerging infectious diseases warrants clinical caution; leaves open need for rigorous trials.
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
No takes yet. Share an insight, caveat, or question.
Farrell et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: